These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 19586052)
21. Synthesis of novel 1,2,4-trioxanes and antimalarial evaluation against multidrug-resistant Plasmodium yoelii nigeriensis. Shukla M; Hassam M; Kumar Yadav D; Sharma S; Singh C; Puri SK; Shrivastava R; Prakash Verma V Bioorg Med Chem Lett; 2021 Oct; 49():128305. PubMed ID: 34365007 [TBL] [Abstract][Full Text] [Related]
22. The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium. Peters W; Robinson BL Ann Trop Med Parasitol; 1991 Feb; 85(1):5-10. PubMed ID: 1888220 [TBL] [Abstract][Full Text] [Related]
23. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice. Tripathi R; Pandey SK; Rizvi A Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423 [TBL] [Abstract][Full Text] [Related]
24. Mefloquine resistance reversal action of ketoconazole - a cytochrome P450 inhibitor, against mefloquine-resistant malaria. Tripathi R; Awasthi A; Dutta GP Parasitology; 2005 May; 130(Pt 5):475-9. PubMed ID: 15991489 [TBL] [Abstract][Full Text] [Related]
25. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria. Win K; Than M; Thwe Y Bull World Health Organ; 1992; 70(6):777-82. PubMed ID: 1486675 [TBL] [Abstract][Full Text] [Related]
26. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C Malar J; 2009 Jan; 8():10. PubMed ID: 19138388 [TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837 [TBL] [Abstract][Full Text] [Related]
28. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria. Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ Malar J; 2009 Apr; 8():58. PubMed ID: 19358697 [TBL] [Abstract][Full Text] [Related]
29. Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children. Sowunmi A; Oduola AM; Ilesanmi AO; Salako LA Ann Trop Paediatr; 1996 Mar; 16(1):5-9. PubMed ID: 8787366 [TBL] [Abstract][Full Text] [Related]
30. New, antimalarial, tricyclic 1,2,4-trioxanes: evaluations in mice and monkeys. Posner GH; Oh CH; Webster HK; Ager AL; Rossan RN Am J Trop Med Hyg; 1994 Apr; 50(4):522-6. PubMed ID: 8166360 [TBL] [Abstract][Full Text] [Related]
31. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family. Posner GH; Parker MH; Northrop J; Elias JS; Ploypradith P; Xie S; Shapiro TA J Med Chem; 1999 Jan; 42(2):300-4. PubMed ID: 9925735 [TBL] [Abstract][Full Text] [Related]
32. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial. Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374 [TBL] [Abstract][Full Text] [Related]
33. Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria. Agomo PU; Meremikwu MM; Watila IM; Omalu IJ; Odey FA; Oguche S; Ezeiru VI; Aina OO Malar J; 2008 Sep; 7():172. PubMed ID: 18782445 [TBL] [Abstract][Full Text] [Related]
35. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand. Looareesuwan S; Wilairatana P; Molunto W; Chalermrut K; Olliaro P; Andrial M Am J Trop Med Hyg; 1997 Sep; 57(3):348-53. PubMed ID: 9311648 [TBL] [Abstract][Full Text] [Related]
36. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. Congpuong K; Bualombai P; Banmairuroi V; Na-Bangchang K Malar J; 2010 Feb; 9():43. PubMed ID: 20132537 [TBL] [Abstract][Full Text] [Related]
37. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers. Peters W; Robinson BL; Mittelholzer ML; Crevoisier C; Stürchler D Ann Trop Med Parasitol; 1995 Oct; 89(5):465-8. PubMed ID: 7495359 [TBL] [Abstract][Full Text] [Related]
38. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Tangpukdee N; Krudsood S; Thanachartwet W; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Wilairatana P; Phongtananant S; Kano S; Looareesuwan S Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1085-91. PubMed ID: 16438129 [TBL] [Abstract][Full Text] [Related]
39. Comparison of effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on rodent malaria. Shao BR; Ye XY; Chu YH Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):59-63. PubMed ID: 1523480 [TBL] [Abstract][Full Text] [Related]
40. Artemisinin derivatives and malaria: useful, in combination with other antimalarials. Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]